-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Core Laboratories Inc. /DE/ quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q2 2022 to Q3 2024.
- Core Laboratories Inc. /DE/ Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $4.69M, a 104% increase year-over-year.
- Core Laboratories Inc. /DE/ Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was $10.1M.
- Core Laboratories Inc. /DE/ annual Income Tax Expense (Benefit) for 2023 was -$4.19M, a 141% decline from 2022.
- Core Laboratories Inc. /DE/ annual Income Tax Expense (Benefit) for 2022 was $10.3M, a 35.2% decline from 2021.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)